We hypothesized that, if mutant plasminogen acts via the KKS, HAE patients with reduced amounts of FXII would have a milder phenotype, as the loss of FXII would counteract the effects of the plasminogen mutation. This evidence concerns the gene PLG and hereditary angioedema.